Baihe Township, Taiwan

Wei-Chao Chang


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):

Title: Wei-Chao Chang: Innovator in Lung Cancer Diagnostics

Introduction

Wei-Chao Chang is a prominent inventor based in Baihe Township, Taiwan. He has made significant contributions to the field of lung cancer diagnostics through his innovative research and patented technologies. His work focuses on the development of diagnostic methods that can improve early detection and treatment of non-small cell lung cancers.

Latest Patents

Wei-Chao Chang holds a patent for "Dermcidin-derived peptides for lung cancer diagnostics." This patent outlines methods for diagnosing non-small cell lung cancers by detecting endogenous peptides in exhaled breath condensate (EBC). The patent introduces diagnostic peptides derived from dermcidin, specifically highlighting a peptide known as E-R11, which has the sequence ENAGEDPGLAR (SEQ ID NO:2). The levels of the E-R11 peptide in EBC, as measured by mass spectrometry (MS), are shown to be highly diagnostic of non-small cell lung cancers. Additionally, the patent provides a method for inhibiting the growth of lung cancer cells by inhibiting DCD expression through RNA interference.

Career Highlights

Wei-Chao Chang is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at Academia Sinica has allowed him to collaborate with leading researchers and contribute to advancements in cancer diagnostics. His innovative approach to utilizing dermcidin-derived peptides has positioned him as a key figure in the field of oncology research.

Collaborations

Wei-Chao Chang has worked alongside notable colleagues, including Chung-Hsuan Chen and Michael Hsiao. Their collaborative efforts have furthered the understanding of lung cancer diagnostics and have the potential to impact clinical practices significantly.

Conclusion

Wei-Chao Chang's contributions to lung cancer diagnostics through his patented innovations demonstrate his commitment to advancing medical science. His work not only enhances diagnostic capabilities but also paves the way for improved patient outcomes in lung cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…